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Determination of the restenosis rate after multilesion
percutaneous transluminal coronary angioplasty is an
important consideration in defining expanded indica-
tions for the procedure. Of 209 patients who underwent
successful multilesion coronary angioplasty, 55 symp-
tomatic and 74 asymptomatic patients were restudied an
average of 7 ± 4 months after dilation. The restenosis
rate was 82% (45 of 55) in the symptomatic patients and
30% (22 of 74) in the asymptomatic patients (p < 0.001).
Only 4% of the asymptomatic patients had restenosis at
more than one dilation site. When only patients who
developed a restenosis were considered, the restenosis
occurred at more than one dilation site in 47% (21 of
45) of the symptomatic group versus 14% (3 of 22) of
the asymptomatic group (p < 0.05). When all recurrent
stenoses were examined, the severity of the luminal nar-
rowing was 270% in 64% (45 of 70) of the stenotic
lesions in the symptomatic patients versus 31% (8 of 26)
Percutaneous transluminal coronary angioplasty is an im-
portant advance in revascularization therapy for selected
patients with single and multivessel coronary disease (I-ll).
Several authors (3-6,8-10) have reported a high primary
success rate, low incidence of in-hospital complications and
marked reduction in anginal symptoms after multilesion
coronary angioplasty. Improved angina status can be ex-
pected even when incomplete revascularization is obtained
(5,10). However, restenosis after coronary angioplasty re-
mains an important limitation of the long-term benefits of
this procedure (12-22) and there is a potential for a higher
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of the stenotic lesions in the asymptomatic patients (p <
0.05).
Proximal left anterior descending coronary artery
disease, increased length of the stenotic narrowing, male
gender and diabetes were associated with an increased
incidence of restenosis by multivariate analysis. Patient-
related variables were not predictive of multilesion re-
stenosis.
In conclusion, the majority of patients are clinically
improved after multilesion coronary angioplasty. Re-
current symptoms after multilesion coronary angio-
plasty are frequently associated with multilesion reste-
nosis and a more severe degree of restenotic narrowing.
Restenosis at more than one dilation site is uncommon
in the asymptomatic patient. The data are useful in for-
mulating guidelines for repeat coronary angiography after
multilesion coronary angioplasty.
(J Am Coli Cardiol1987;LO:246-52)
rate of restenosis in patients who undergo multilesion-mul-
tivessel coronary angioplasty. Clearly, the rate of restenosis
after multilesion-multivessel coronary angioplasty will play
a critical role in the future development of indications for
coronary angioplasty in patients with multivessel disease.
To address this issue, we analyzed the incidence of reste-
nosis in 55 symptomatic and 74 asymptomatic patients who
underwent successful multi lesion coronary angioplasty and
had a repeat coronary angiogram.
Methods
Study patients. Of 571 consecutive patients who under-
went their first elective coronary angioplasty at St. Louis
University Medical Center from May 1983 to June 1985,
244 (43%) had a dilation attempt of at least two stenotic
lesions during the same procedure. Patients who were stud-
ied within 48 hours of acute myocardial infarction were
excluded. The cohort of 571 patients includes 128 patients
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who were referred for coronary angioplasty after diagnostic
catheterization at another hospital and 342patientswho were
selected from 3,522 patients who underwent cardiac cath-
eterization and were found to have obstructive coronary
disease at our hospital during the same time interval. The
angioplasty procedure was performed using standard tech-
niques and a steerable catheter system. The patient selection
criteria for multilesion coronary angioplasty at our institu-
tion have been previously described (5). Clinical and an-
giographic characteristics of the 209 patients who had at
least two lesions successfully dilated are described in Table
I. Of the 209 patients, 129 returned for follow-up coronary
angiography . Calcium channel blocker drugs (nifedipine,
40 rug/day or diltiazem, 120 mg/day) and antiplatelet drug
therapy (aspirin, 325 mg/day and dipyridamole, 225 mg/day)
were recommended for a minimum of 6 months.
Cardiac catheterization. Multivessel disease was de-
fined as a luminal arterial diameter narrowing :2:70% in at
least one major vessel and :2:50% stenosis in one or more
additional major vessels. Coronary stenoses were expressed
as percent luminal diameter narrowing compared with the
nearest normal arterial segment. All lesions were measured
using calipers in at least two perpendicular views, and the
average of both views determined the percent reduction in
luminal diameter. An attempt was made to obtain similar
views of the precoronary and postcoronary angioplasty and
follow-up coronary angiogram. The ratio of the measured
to actual dimension of the guiding catheter was used to
correct for X-ray magnification. The projection displaying
the longest aspect of the lesion was used and the lesion was
measured from where tapering began to where widening
ended. The lesion length was classified as $5, 6 to 10, I I
to 19and :2:20 mm after correction for X-ray magnification.
The presence or absence of an eccentric lesion or coronary
artery calcification was coded.
Angiographic success was definedas a 30% reduction in
luminal diameter stenosis and residual narrowing < 50%.
The patient was considered to have a clinical success when
the dilation of the most critical stenosis or all lesions at-
tempted was achieved with immediate clinical improvement
in anginal status and without major in-hospital complica-
tions.
The maximal inflation pressure in atmospheres, the max-
imal duration of inflation at any pressure level in seconds
and the number of inflations/lesion were recorded. Inflated
balloon diameter was measured for each lesion and the di-
ameter of the nearest nondiseased coronary artery was de-
termined. If several dilations were performed, the largest
balloondiameterwas recorded and correctedfor X-ray mag-
nification. Balloon/artery diameter ratio wascalculated from
the corrected values for diameter of the balloon and artery.
Noncomplicated intimal coronary dissection was defined
using criteria described in the National Heart, Lung. and
Blood Institute registry (23).
Follow-up. An elective repeat coronary angiogram was
recommended to all patients 6 months after the coronary
angioplasty procedure or earlier if clinically indicated. Pro-
gressionof coronarydiseasewasdefinedas a :2:20% increase
in luminal diameter narrowing at the site of a previous
stenosis resulting in a stenotic diameter :2:50%, the ap-
pearance of a new atherosclerotic narrowing :2:50% or total
coronary occlusion. The angiographic criterion for reste-
nosis was defined as a luminal diameter narrowing :2:50%
in a previously dilated artery. All patients with a primary
Table I. Baseline Clinical Characteristics of the 209 Patients After Successful Multilesion Coronary Angioplasty
Patients Who Had Patients Who Did
Repeat Not Have Repeat
Angiography Angiography Total
Variable
No. of patients 12Y 110 20Y
Average age (range) (yr) Sf> <2Y to 711) 57 en to 76) 56 (29 to 78)
Male Y7 511 ISS
CCS angina class 2:III f>6 57* 123
AMI history 41 37 711
CABG history I I 12 23
Multivessel CAD Y5 57 152
LV score 2:10 If> I I 27
No. of patients with two or more vessels 7Y 50 12Y
attempted
No. of lesions attempted/patient 2.7 (34Y!129) 2.7 (215/80) 2.7 (5641209)
No. of lesions successfully dilated 329 199 52!!
% Diameter stenosis
Before PTCA 70 ± 16 73 ± 17 71 ± 16
After PTCA 23 ± 12 22 ± 13 23 ± 12
*p < 0.01. AMI = acute myocardial infarction; CABG = coronary bypass graft surgery; CAD = coronary artery disease; CCS = Canadian
Cardiovascular Society; LV = left ventricular; PTCA = percutaneous transluminal coronary angioplasty.
248 VANDORMAEL ET AL.
MULTILESION CORONARY ANGIOPLASTY
JACC Vol. 10. No.2
August 1987:246-52
o No Restenosis 0 Reslenosis • Restenosis mProgression
No Progression 1 Lesion > 1 Lesion




Our. F-UP 8+4 Months





Figure 2. Angiographic follow-up (F-UP) aft~r successful mul-
tilesion coronary angioplasty in 55 syrnptomanc and 74 asymp-
tomatic patients (Pt.), Single and multilesion restenoses (Rest.)
were more common in the symptomatic patients (p < 0.001; see
text). Our. = duration.
Figure 1. Angiographic follow-up of 209 patients after successful
multilesion coronary angioplasty. Follow-up (F-UP) angiograms
(Angio) were obtained in 85% of the 65 symptomatic patients and
53% of the 139 asymptomatic patients.
The frequency of exercise-induced ST segment depres-
sion ;:::: I mm was 31 compared with 29% in the asympto-
matic patients who did and did not undergo repeat coronary
angiography (p = NS).
Incidence of restenosis. When the 129 patients who
underwent repeat coronary angiography were considered,
restenosis occurred at one dilation site in 33% of patients
and at more than one dilation site in an additional 19%.
Progression of coronary disease progression occurred in 6%.
Among the 55 patients with recurrent symptoms, 45 (82%)
had restenosis and 5 (9%) had disease progression (Fig. 2).
Of five symptomatic patients who did not have restenosis
or disease progression, three had incomplete revasculari-
zation. Among the 74 asymptomatic patients, the incidence
of restenosis and disease progression was 30% (p < 0.001)
and 4% (p = NS), respectively. When only patients who
developed restenosis were considered, the proportion that
developed restenosis at more than one dilation site was
significantly less in the asymptomatic than in the sympto-
matic group (3 [14%] of 22 versus 21 [47%] of 45; P <
0.05).
Results
Angiographic success was obtained in 94% of the 564
lesions attempted in the 209 patients. The mean transtenotic
diameter narrowing was decreased from 71 ± 16 to 23 ±
12%. The average number of lesions dilated per patient was
2.7. The baseline clinical, angiographic and procedural vari-
ables of the patients who underwent follow-up angiography
were similar to those that did not with the exception of
anginal symptoms (Canadian Cardiovascular Society ;:::: class
III), which were less common in the group that underwent
repeat cardiac catheterization (Table I).
Of the 129 patients who underwent repeat angiography,
55, 61 and 13patients had one, two and three vessel dilation,
respectively. The number of lesions successfully dilated was
2 and ;::::3 in 47 and 8 patients, respectively, with single
vessel dilation, 38 and 23 patients with two vessel dilation
and 2 and II patients with three vessel dilation.
Clinical and angiographic follow-up. The average du-
ration of follow-up was 7 ± 4 months in the 129 patients
who underwent repeat angiography and 16 ± 7 months in
the 75 patients who did not. Five patients were lost to follow-
up (Fig. I). The average time between coronary angioplasty
and follow-up angiography was 5 ± 4 months in the symp-
tomatic patients versus 8 ± 4 months in the asymptomatic
group (p = 0.0003). There were no significant differences
between patients with recurrent symptoms and asympto-
matic patients in relation to the number of attempted lesions,
number of successfully dilated lesions and mean diameter
stenosis or mean pressure gradient after coronary angio-
plasty. Of the 129 patients who underwent repeat angiog-
raphy, 77% were on calcium channel blocker therapy and
56% on antiplatelet therapy at the time of the control an-
giogram. The percent of patients on calcium channel blocker
and antiplatelet therapy was similar in both groups.
success were contacted regarding symptomatic status and
presence or absence of cardiac complications. A minimal 6
month follow-up was required for patient inclusion.
Statistical analysis. Univariate analysis was performed
using the chi-square test for categorical variables and the
Student's t test or one-way analysis of variance (ANOYA)
for continuous variables. Multivariate analysis was per-
formed using a stepwise logistic regression to identify pa-
tient-related or procedure-related variables predictive of re-
stenosis (24) (see Appendix). The probability (p) values for
the variables remaining in the final model were calculated
from the coefficient/standard error ratios. Odds ratios for
each of the selected variables were calculated as an expo-
nential function of the coefficient (25).
The patient-related variables with respect to absence of
restenosis, restenosis at one site and restenosis at multiple
sites were assessed using a stepwise discriminant analysis
(26). An F value of 4 was used to enter or remove variables.
A p value <0.05 was considered statistically significant.
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Figure 5. The restenosis rate in 316 lesions according to artery
dilated and location of the coronary artery narrowing. Restenoses
were more common in the proximal (PROX) segments of the left
anterior descending (LAD) and circumflex (CX) coronary arteries
(p < 0.001). DIST = distal; RCA = right coronary artery.
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Discussion
Restenosis rate after angioplasty. The precise rate of
restenosis after multi lesion percutaneous transluminal coro-
nary angioplasty is best determined by complete angio-
graphic follow-up. We were able to restudy 62% of our
patients, similar to the reported angiographic follow-up rates
in U.S. medical centers in recent years (6,17,18,21). The
range of restenosis rates reported after multilesion and mul-
tivessel coronary angioplasty is 26 to 50% (6,17,18,21) with
one study reporting a restenosis rate of 68% after multivessel
angioplasty (22). The restenosis rate per patient was 50%
in our study, within the 26 to 68% range reported in other
series (6,17,18,21,22). The exact restenosis rates in the
reported series are biased by a greater percent of sympto-
matic patients being restudied and would be lower if a con-
secutive group of patients with multilesion coronary angio-
plasty underwent repeat coronary angiography. Mata et al.
(9) reported a 34% restenosis rate in a series of 61 Canadian
patients who underwent successful double vessel angio-
plasty, 97% of whom were restudied 6 months later.
Symptomatic status. The return of ischemic symptoms
in patients with multi vessel coronary angioplasty may in-
dicate incomplete revascularization, single or multilesion
Figure 4. The restenosis rate in 313 lesions according to initial
lesion length at the time of coronary angioplasty. A trend toward
increased restenosis rates was observed with increasing length of
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Figure 3. The restenosis rate per lesion stratified by symptoms.
The proportion of lesions with restenosis 2:70% are significantly
greater (32%) in the symptomatic patients. Only 4% of lesions
dilated in asymptomatic patients (Pts.) had a restenotic narrowing
2:70% (p < 0.001; see text).
The 129 patients who underwent repeat coronary angi-
ography had 329 lesions dilated. The restenosis rate per
lesion was 29% (Fig. 3). When only restenotic lesions were
considered, the degree of restenotic narrowing was 2:70%
in 64% (45 of 70) of the stenotic lesions in the symptomatic
patients versus 31% (8 of 26) of the stenotic lesions in the
asymptomatic group (p < 0.05).
Single vessel versus multivessel dilation. Angiographic
follow-up was obtained in 65 and 60% of the patients who
underwent single vessel and multi vessel dilation, respec-
tively. Restenosis occurred in 45% of the 55 patients with
single vessel multi lesion dilation and in 57% of the 74
patients who had multivessel dilation (p = NS). The re-
stenosis rate per lesion was similar in both groups. Pro-
gression of coronary disease occurred in II % of patients
with single vessel disease and 3% of patients with multi-
vessel disease (p = NS). The incidence of recurrent symp-
toms and duration of follow-up was similar in both groups.
Clinical and procedural variables related to reste-
nosis. The restenosis rate progressively increased with in-
creasing length of the stenotic narrowing (p < 0.00 I) (Fig.
4). Restenosis was most common for proximal left anterior
descending coronary lesions and least common for right
coronary artery stenoses (p < 0.001) (Fig. 5). Restenosis
occurred more frequently in men (57 versus 30%; p = 0.0 I)
and in diabetic patients (71 versus 46%; p = 0.035).
Multivariate analysis of 13 angiographic procedure-re-
lated variables revealed that the left anterior descending
coronary artery, proximal location of the coronary narrow-
ing within the vessel and long (2: IO mm) coronary artery
narrowing were significantly associated with an increased
restenosis rate (Table 2). When the analysis was repeated
using 14 patient-related variables, diabetes mellitus and male
gender were the only two clinical variables selected (Ap-
pendix). Multivariate discriminant analysis of the patient-
related factors did not reveal any variables predictive of
multi lesion restenosis.
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Table 2. Multiple Logistic Regression Analyses of Patient-Related and Angiographic Procedural-Related Variables
Relating to Restenosis
Coefficient SE ClSE Odds Ratio p Value
Clinical variable
Diabetes mellitus 0.661 0.280 2.36 1.94 <0.05
Male sex 0.658 0.239 2.75 1.93 <0.01
Constant 0.112
Angiographic and procedural variables
Left anterior descending artery 0.395 0.142 2.92 1.48 <0.005
Proximal lesions 0.319 0.142 2.24 1.38 <0.05
Length of lesion
a (>20 mm) 1.014 0.558 1.82 2.75 >0.05
b (II to 19 mm) 0.595 0.357 1.52 1.72 >0.1
c I'<f Omm) -0.697 0.279 -2.50 -2.0 <0.05
Constant 0.153
*ClSE = coefficient/SE ratio.
restenosis and progression of coronary disease or a com-
bination of these factors. The restenosis rate among our 55
symptomatic patients who underwent multilesion coronary
angioplasty was 82%, greater than the 50% rate observed
by Mata et al. (9) in 34 symptomatic patients who underwent
two vessel coronary angioplasty. The difference between
the two series may be explained in part by the definition of
restenosis, which required 2:70% narrowing in the Montreal
Heart Institute study versus 50% in our study, by patient
selection factors and by the inclusion of patients with more
diffuse disease (that is, three vessel disease) in the present
study.
The most common cause ofrecurrent ischemic symptoms
in the year after multilesion coronary angioplasty is reste-
nosis. Our data confirm and extend previous observations
that progression of coronary disease in dilated or nondilated
arteries is uncommon during the initial year after coronary
angioplasty (15,27) and that incomplete revascularization is
an uncommon cause of recurrent symptoms in patients who
do not have restenosis or coronary disease progression (27).
The majority ofpatients in our series were asymptomatic
during the year after the multilesion coronary angioplasty.
The restenosis rate among these asymptomatic patients was
29%. Among the patients who developed restenosis, the
degree of restenotic narrowing often ranged between 50 and
70%, in contrast to the more severe degree of restenotic
narrowing seen in symptomatic patients. Multilesion reste-
nosis is a rare event in asymptomatic patients. The restenosis
rate in our series was similar among patients who underwent
multiple dilations in the same vessel versus those with di-
lation in multiple vessels, a finding similar to that of a
previous report (19) but in contrast to the findings of Roubin
et al. (21).
Predictors of restenosis. The proximal left anterior de-
scending coronary artery was associated with the greatest
incidence of restenosis, confirming previous reports
(9,16,22,28). It is not clear why this particular coronary
site is associated with a higher restenosis rate. In our mul-
tivariate analysis, balloon/artery diameter mismatch was
not selected as a factor predictive of restenosis (9,13,16).
Anatomic and structural features of the proximal seg-
ment of the left anterior descending coronary artery differ
from the proximal segments of the right coronary and left
circumflex vessels (29). Numerous authors (9,12,13,15,
16,20-22,28,30-35) have analyzed factors predictive of
restenosis after coronary angioplasty. Similarities and
differences between the present study and others relate in
part to sample size and choice of variables considered
for analysis. We did not identify any patient-related var-
iables predictive of multi lesion restenosis in contrast to
the findings of Shaw et al. (35). In our analysis, restenosis
was defined as a trichotamous outcome variable (none, one,
multiple) rather than a dichotomous variable (all or none).
Shaw et al. (35) described diabetes, hypercholesterolemia,
smoking history and duration of angina as variables that
were more common in patients who developed restenoses
of all lesions dilated.
If restenosis is related to clinical or systemic factors that
affect each dilated segment equally, there would be a high
incidence of multiple lesion recurrence in patients after mul-
tiple dilations. If restenosis is related to anatomic, proce-
dural or local factors for each stenosis, then the incidence
of multiple restenosis may not necessarily be markedly in-
creased. In our study, multiple lesion restenosis did not
occur in the majority of patients who underwent multilesion
coronary angioplasty, nor did we identify any clinical vari-
ables as predictive of multilesion restenosis. The data sug-
gest that systemic or clinical factors, in general, do not play
an instrumental role in the pathogenesis of multiple lesion
recurrence.
The choice ofpharmacologic therapy after coronary an-
gioplasty may be important in influencing the restenosis rate
(36). The optimal choice of drug therapy to prevent reste-
nosis after coronary angioplasty is an area of active inves-





tigation (37-39). In our study, antiplatelet drug therapy and
calcium channel blockers were recommended for a mini-
mum of 6 months. At the time of the angiographic follow-
up, 77% of our patients were receiving calcium channel
blockers and 56% were receiving antiplatelet drug therapy.
Clinical implications. The majority of patients remain
asymptomatic or are clinically improved during the year
after multi lesion coronary angioplasty, and this remains an
important objective of the procedure, However, the likeli-
hood that a restenosis may occur in a patient who undergoes
multiple dilations is greater than that reported after single
lesion angioplasty (12,14,16), A higher rate of restenosis
at one of several dilation sites in a patient with extensive
coronary disease should not be a deterrent in recommending
multi lesion coronary angioplasty to selected patients with
multivessel disease, because the procedure provides im-
portant symptomatic relief to the majority of patients. Fur-
thermore, recurrent narrowings are usually amenable to a
second dilation attempt if clinically indicated because of
unacceptable symptomatic limitation.
Appendix
A considerable proportion of patients with recurrent
symptoms after multi lesion coronary angioplasty have re-
stenosis that may occur at more than one dilation site and,
as a group, such patients tend to have a more severe degree
of restenotic narrowing than do asymptomatic patients. Thus,
evidence for important myocardial ischemia on noninvasive
testing in a symptomatic patient after multilesion coronary
angioplasty should lead to a recommendation for repeat
coronary angiography. In the asymptomatic patient after
multi lesion coronary angioplasty, restenosis at more than
one dilation site is rare. Our data suggest that repeat coro-
nary angiography is not required in the vast majority of
asymptomatic patients in the year after multi lesion angio-
plasty if the aim of the procedure is to uncover those patients
who may have silent multivessel coronary disease as a result
of multiple restenoses.
We thank the Mudd Cardiac Catheterization Laboratory team of St. Louis
University Hospital and Mary Streif and Susan Buenger for manuscript
preparation.
Variables Tested for the Prediction of Restenosis by Univariate and Multivariate Analyses
Patient-Related Variables
(n = 129; 329 lesions)
Age
Sex
History of diabetes mellitus
History of hypertension
History of smoking
Family history of coronary artery disease
Cholesterol level at time of PTCA*
Onset of symptoms within 2 months
CCS angina class dII or <lll
History of unstable angina
History of myocardial infarction
No. of diseased vessels
No. of attempted dilations
No. of successful dilations
Single vessel multilesion versus multivessel dilation
Procedure-Related Variables
(n = 125; 316 lesions)
Pre-PTCA stenosis ('Yo)
Post-PTCA stenosis (%)
Pre-PTCA transstenotic gradient (mm Hg)*
Post-PTCA transstenotic gradient (mm Hg)*
Maximal duration of inflation (seconds)




Proximal versus distal lesion location
Vessel dilated (RCA, LAD, or LCx)
Eccentric versus concentric lesion
Length of lesion!
Presence of lesion calcification
Presence of uncomplicated intimal dissection
*Variables not tested in multivariate analysis. tn = 124; 313 lesions. CCS = Canadian Cardiovascular Society; LAD = left anterior descending
coronary artery; LCx = left circumflex coronary artery; PTCA = percutaneous trans luminal coronary angioplasty: RCA = right coronary artery.
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